Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone vs Deferasirox in Paediatric Patients with Transfusion Dependent Haemoglobinopathies
NCT01825512Phase 3Completed
- Sponsor
- Consorzio per Valutazioni Biologiche e Farmacologiche
- Start
- Mar 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of deferiprone in hemochromatosis (HH), sponsored by Consorzio per Valutazioni Biologiche e Farmacologiche. Started Mar 2014; status: completed.
02
Drugs
deferiprone
03
Conditions
hemochromatosis (HH)
Beyond the preview
Go deeper on NCT01825512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825512.